Impact of switching to single dosing regimen of antipsychotics on medication adherence in schizophrenia: A randomized controlled trial
Not Applicable
Recruiting
- Conditions
- Schizophrenia
- Registration Number
- JPRN-UMIN000037946
- Lead Sponsor
- Yamanashi Prefectural Kita Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Having serious medical conditions (2) Having a history of mental and behavioral disorders due to psychoactive substance use (3) Being pregnant or lactating (4) Being incapable to understand Japanese language (5) Having a history of blood sampling-induced vasovagal reaction (6) Being judged as inappropriate by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Medication adherence at 12 weeks after intervention
- Secondary Outcome Measures
Name Time Method Positive and Negative Syndrome Scale (PANSS); Brief Evaluation of Psychosis Symptom Domains (BE-PSD); Clinical Global Impression - Global Severity (CGI-S); Brief Assessment of Cognition in Schizophrenia (BACS); Personal and Social Performance Scale (PSP); Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS); UKU Side Effect Rating Scale (UKU-SERS); Subjective well-being under neuroleptic drug treatment short form (SWNS); Perceived Deficits Questionnaire (PDQ); Visual Analogue Scale for Distress Associated with Symptoms (VAS-DAS); blood sampling for general test, plasma assay at start and 12 weeks after intervention